RxDoctor Payments Data

Niveditha Meghadri, MD

Psychiatry · Edison, NJNPI 1063501872

Payments from drug & device makers

$2,624in general payments, 2019–2025

Across 237 payments — averaging $11.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$754
  • Otsuka America Pharmaceutical, Inc.$697
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$451
  • Axsome Therapeutics, Inc.$105
  • Vanda Pharmaceuticals Inc.$105
  • Sunovion Pharmaceuticals Inc.$98
  • plus $413 from 9 others

What the payments were for

  • Food & beverage$2,624100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,624 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in New Jersey.

See all psychiatry providers in New Jersey

Medicare billing

Part B allowed, 2024
$9,552
Medicare patients
31
Services billed
136

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abilify MaintenaAripiprazole26$65,531
VraylarCariprazine Hcl27$53,652
Invega SustennaPaliperidone Palmitate18$50,648
RexultiBrexpiprazole11$29,009
Aripiprazole235$12,181
Quetiapine Fumarate452$6,641
Fluvoxamine Maleate ErFluvoxamine Maleate13$5,450
Bupropion XlBupropion Hcl236$4,644
Duloxetine Hcl192$3,992
Clonazepam250$2,360
Buspirone Hcl154$2,210
Olanzapine133$2,054
Mirtazapine155$1,878
Venlafaxine Hcl ErVenlafaxine Hcl163$1,670
Fluphenazine Hcl17$1,548

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$697$94,54037 claims
AbbVieVraylar$754$53,65227 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,119 psychiatry providers in New Jersey.

Other psychiatry in Edison

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →